Dedicated post-treatment monitoring and specialized maintenance protocols focused on proactive surveillance and the long-term preservation of gynecologic health

Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis. 

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

Surveillance and Detecting Recurrence

Surveillance and Detecting Recurrence

Following the completion of primary treatment, patients enter a phase of active surveillance. The risk of recurrence in ovarian cancer is high, particularly for advanced stages. Surveillance protocols typically involve physical examinations and CA-125 blood testing every 3 to 4 months for the first 2 years, then spacing out intervals as time progresses.

The use of routine CT scans in asymptomatic patients is debated. While they can detect recurrence early, studies have shown that starting chemotherapy solely based on rising CA-125 levels (before symptoms appear) does not improve overall survival compared to waiting for symptoms. Therefore, many guidelines suggest treating the patient, not the number. Scans are ordered if CA-125 rises significantly or if the patient develops new symptoms.

Recurrent disease is classified based on the “platinum-free interval.” If the cancer returns more than six months after the last platinum chemo, it is “platinum-sensitive” and can be treated with platinum again. If it returns within six months, it is “platinum-resistant,” requiring different drugs (like Liposomal Doxorubicin or Gemcitabine) and clinical trials.

  • Surveillance involves regular CA-125 monitoring and physical exams.
  • Routine imaging is triggered by symptoms or by elevated biomarkers.
  • Early treatment of asymptomatic recurrence does not continually improve survival.
  • Platinum-free interval determines the strategy for second-line treatment.
  • Platinum-sensitive recurrence has a more favorable prognosis.
Icon LIV Hospital

Managing Surgical Menopause

Managing Surgical Menopause

Because treatment often involves the removal of both ovaries (bilateral oophorectomy), premenopausal women are plunged into immediate, surgical menopause. This is more abrupt and severe than natural menopause. Symptoms include intense vasomotor instability (hot flashes), sleep disturbances, vaginal dryness, and mood changes.

Management requires a nuanced approach. For women with high-grade serous carcinoma, hormone replacement therapy (HRT) is generally considered safe and effective for managing quality of life, as these tumors are not typically driven by estrogen. This helps mitigate the severe symptoms and protects cardiovascular and bone health.

However, for survivors of endometrioid or low-grade serous carcinomas, which may be hormonally sensitive, HRT is used with caution or avoided. Non-hormonal alternatives, such as certain antidepressants (SSRIs) or gabapentin, can help manage hot flashes. Vaginal moisturizers and lasers can address local atrophy.

  • Surgical menopause causes the abrupt cessation of sex hormones.
  • Vasomotor symptoms are often severe and disruptive.
  • HRT is generally safe for high-grade serous carcinoma survivors.
  • Endometrioid subtypes require cautious hormonal management.
  • Non-hormonal therapies offer alternatives for symptom control.
Icon 1 LIV Hospital

Bone Health and Neuropathy

Bone Health and Neuropathy

Long-term survivorship care must address the treatment sequelae. Chemotherapy, specifically Paclitaxel, often causes Peripheral Neuropathy—numbness, tingling, or pain in the hands and feet. This nerve damage can be permanent. Management includes medications such as duloxetine, balance-based physical therapy, and safety education (avoiding extreme temperatures).

Bone health is another critical domain. The loss of estrogen from ovary removal, combined with the potential use of steroids during chemo, accelerates bone density loss, leading to osteoporosis. Survivors require regular DEXA scans to monitor bone mass. Calcium and Vitamin D supplementation are standard, and bone-strengthening medications (bisphosphonates or denosumab) may be prescribed if osteopenia develops.

Additionally, “chemo-brain” or cognitive fog is a reported long-term effect. Cognitive rehabilitation and occupational therapy can help survivors develop strategies to manage memory and concentration deficits, facilitating a return to work and daily life.

  • Peripheral neuropathy is a common, often lasting, side effect of taxanes.
  • Estrogen loss accelerates bone resorption and increases the risk of osteoporosis.
  • DEXA scans are essential for monitoring skeletal integrity.
  • Pharmacologic intervention preserves bone density in high-risk patients.
  • Cognitive rehabilitation addresses cancer-related cognitive impairment.

Palliative Management of Bowel Obstruction

Palliative Management of Bowel Obstruction

In the setting of recurrent or advanced disease, malignant bowel obstruction (MBO) is a challenging complication. The cancer implants can kink the bowel or inhibit its movement (ileus). Symptoms include nausea, vomiting, and abdominal pain.

Management is often palliative, focusing on symptom relief rather than fixing the blockage surgically, as surgery in this setting carries high risks. A “venting gastrostomy” (PEG tube) can be placed in the stomach. This tube allows gas and fluid to drain into a bag, relieving pressure and stopping vomiting. This allows the patient to eat small amounts for pleasure and drink liquids without distress.

Medications such as corticosteroids (to reduce swelling around the tumor), antiemetics (to treat nausea), and octreotide (to reduce gastrointestinal secretions) are used to manage the obstruction. This aggressive symptom management allows patients to remain at home rather than in the hospital.

  • Malignant bowel obstruction is a common complication of advanced recurrence.
  • Venting gastrostomy (PEG) provides profound relief from nausea/vomiting.
  • Surgery for MBO is high-risk and reserved for carefully selected patients.
  • Octreotide reduces digestive secretions, thereby lowering pressure.
  • Focus shifts to comfort and enabling home-based care.

Management of Malignant Ascites

Management of Malignant Ascites

Recurrent ascites can severely impact quality of life by causing distension, pain, and breathlessness. When diuretics (water pills) are no longer effective, repeated paracentesis (drainage) is required.

For patients requiring frequent drainage, an indwelling tunneled catheter (like a PleurX drain) can be placed. This allows the patient or a family member to drain the fluid at home as needed, avoiding frequent hospital visits. This autonomy significantly improves quality of life.

Intraperitoneal therapies, such as catumaxomab infusion (where approved) or palliative HIPEC, are sometimes considered to reduce fluid production. Still, the mainstay remains mechanical drainage and systemic therapy (such as bevacizumab) to reduce vascular permeability.

  • Recurrent ascites causes mechanical compression and respiratory distress.
  • Indwelling catheters enable home-based fluid management.
  • Home drainage reduces hospital dependence and improves autonomy.
  • Systemic angiogenesis inhibitors help reduce fluid production.
  • Symptom control takes precedence in the palliative setting.

30 Years of
Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical

Book a Free Certified Online
Doctor Consultation

Clinics/branches

Was this article helpful?

Was this article helpful?

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

FREQUENTLY ASKED QUESTIONS

How long do I need to take maintenance therapy?

For PARP inhibitors, the standard duration is usually two years for first-line maintenance, or until the disease progresses. Some patients on Bevacizumab may take it for about 15 months. The exact duration depends on the specific drug, side effects, and clinical trial data relevant to your situation.

Neuropathy can be stubborn. While nerves heal very slowly, medications like gabapentin or duloxetine can mask the pain. Physical therapy is crucial for improving balance and preventing falls. Acupuncture has also shown benefit for some patients in relieving the discomfort of chemotherapy-induced neuropathy.

Not definitely, but it is a strong sign. A consistent rise in CA-125 across multiple tests is more meaningful than a single high value. However, inflammation or other benign issues can sometimes cause fluctuations. Your doctor will usually order a CT or PET scan to confirm if there is visible tumor recurrence before starting treatment.

A venting PEG tube is for drainage, but many patients can still eat small amounts of food for pleasure (comfort feeding). The food might drain out of the tube, but the patient gets to taste and enjoy the meal without the pain and vomiting associated with a blockage. It is about quality of life, not calories.

Yes, and it is highly encouraged. Exercise helps combat fatigue, improves mood, maintains bone density, and may even improve immune function. It is essential to listen to your body and adapt the intensity, but staying active is a key part of survivorship and recovery.

Spine Hospital of Louisiana

Let's Talk About Your Health

BUT WAIT, THERE'S MORE...

Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.

Let's Talk About Your Health

Let's Talk About Your Health

Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.

Let's Talk About Your Health

How helpful was it?

helpful
helpful
helpful
Your Comparison List (you must select at least 2 packages)